Covestor’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$147K Sell
1,057
-342
-24% -$47.9K 0.1% 155
2025
Q4
$172K Sell
1,399
-517
-27% -$62.8K 0.09% 281
2025
Q3
$213K Buy
1,916
+953
+99% +$108K 0.12% 188
2025
Q2
$107K Sell
963
-480
-33% -$51.1K 0.06% 517
2025
Q1
$161K Sell
1,443
-472
-25% -$48.7K 0.11% 225
2024
Q4
$177K Sell
1,915
-423
-18% -$38.1K 0.11% 227
2024
Q3
$196K Sell
2,338
-2,552
-52% -$195K 0.12% 178
2024
Q2
$336K Buy
4,890
+1,665
+52% +$111K 0.22% 44
2024
Q1
$236K Buy
3,225
+553
+21% +$42.5K 0.15% 111
2023
Q4
$216K Sell
2,672
-1,398
-34% -$109K 0.15% 113
2023
Q3
$305K Buy
4,070
+665
+20% +$51.1K 0.23% 42
2023
Q2
$263K Buy
3,405
+648
+24% +$51.7K 0.2% 58
2023
Q1
$229K Sell
2,757
-329
-11% -$27.2K 0.2% 72
2022
Q4
$265K Sell
3,086
-660
-18% -$52.3K 0.22% 63
2022
Q3
$231K Sell
3,746
-1,119
-23% -$70.6K 0.2% 62
2022
Q2
$301K Sell
4,865
-129
-3% -$7.99K 0.24% 52
2022
Q1
$297K Buy
4,994
+2,698
+118% +$172K 0.2% 60
2021
Q4
$167K Buy
+2,296
New +$158K 0.23% 45

Other funds holding GILD

Covestor's GILD Position: Q1 2026 in Review

Covestor reduced its Gilead Sciences (GILD) stake by 24% in Q1 2026, selling an estimated $47.9K and leaving 1,057 shares worth $147K. The position accounts for 0.1% of the portfolio, ranked #155.

Covestor first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $336K in Q2 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Covestor held 1,057 shares of Gilead Sciences worth $147K as of Q1 2026.
  • Covestor sold 342 Gilead Sciences shares in Q1 2026, an estimated $47.9K.
  • Gilead Sciences made up 0.1% of Covestor's portfolio in Q1 2026, its #155 holding.
  • Covestor first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Gilead Sciences position peaked at $336K in Q2 2024.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.